Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment

QR Code

Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment

© 2017 Elsevier B.V. Nanoparticles have demonstrated significant advancements in potential oral delivery of insulin. In this publication, we review the current status of polymeric, inorganic and solid-lipid nanoparticles designed for oral administration of insulin. Firstly, the structure and physiol...

Full description

Bibliographic Details
Main Authors:	Wong, C., Al-Salami, Hani, Dass, Crispin
Format:	Journal Article
Published:	Elsevier 2017
Online Access:	http://hdl.handle.net/20.500.11937/57215

Similar Items

Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities
by: Wong, C., et al.
Published: (2016)

Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus
by: Wong, Chun Yuen, et al.
Published: (2018)

The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.
by: Wong, C., et al.
Published: (2017)

Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin
by: Wong, C., et al.
Published: (2018)

Oral insulin delivery: existing barriers and current counter-strategies
by: Gedawy, A., et al.
Published: (2017)

Evaluation of Chitosan-Based Nanoparticles in Oral Delivery of Insulin
by: Wong, Chun Yuen Jerry
Published: (2020)

Treatment of lung cancer using nanoparticle drug delivery systems
by: Chandolu, V., et al.
Published: (2013)

Alginate-deoxycholic Acid Interaction and Its Impact on Pancreatic ?-Cells and Insulin Secretion and Potential Treatment of Type 1 Diabetes
by: Mooranian, Armin, et al.
Published: (2016)

Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System
by: Negrulj, Rebecca, et al.
Published: (2013)

Oral insulin delivery system based on chitosan-completed carboxymethylated iota-carrageenan nanoparticles / Pratyusa Sahoo
by: Pratyusa, Sahoo
Published: (2019)

Intraperitoneal delivery of nanoparticles for cancer gene therapy
by: Hallaj-Nezhadi, Somayeh, et al.
Published: (2013)

Enhanced Synthesis and Delivery of Magnesium Oxide Nanoparticles for Reverse Insulin Resistance in Type 2 Diabetes Mellitus
by: Jeevanandam, Jaison
Published: (2017)

Design of alginate nanoparticles as oral insulin carrier / Aminah Kadir
by: Kadir, Aminah
Published: (2015)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)

Quantification of BSA-loaded chitosan/oligonucleotide nanoparticles using reverse-phase high-performance liquid chromatography
by: Wong, Chun Yuen, et al.
Published: (2018)

An update on type 1 diabetes treatments: insulin treatment, cell therapy and transplantation
by: Hani, Homayoun, et al.
Published: (2018)

Developing an Oral-Insulin-Delivery System using GET-peptide-mediated transcytosis
by: Rehmani, Sahrish
Published: (2021)

Drug delivery in cancer using liposomes
by: Dass, Crispin
Published: (2008)

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes
by: Negrulj, R., et al.
Published: (2015)

Transdifferentiation of adipocytes to osteoblasts: potential for orthopaedic treatment
by: Lin, D., et al.
Published: (2018)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

Effect of formulation variables on insulin localisation within solid lipid nanoparticles
by: Thong, Li Ming
Published: (2016)

Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
by: Mooranian, Armin, et al.
Published: (2014)

Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic ß-cell line
by: Mooranian, A., et al.
Published: (2015)

The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes
by: Mathavan, S., et al.
Published: (2015)

In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor
by: Wong, C., et al.
Published: (2017)

PEDF-induced alteration of metabolism leading to insulin resistance
by: Carnagarin, Revathy, et al.
Published: (2015)

Self-assembled insulin and nanogels polyelectrolyte complex (Ins/NGs-PEC) for oral insulin delivery: Characterization, lyophilization and in-vivo evaluation
by: Mudassir, Jahanzeb, et al.
Published: (2019)

Biodegradable drug delivery systems for cancer therapy
by: Wong, T., et al.
Published: (2017)

Design of pectinate nanoparticles as oral insulin carrier / Mohammad Tarmizi Mohd Mokhtar
by: Mohd Mokhtar, Mohammad Tarmizi
Published: (2014)

Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)

The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes
by: Mooranian, Armin, et al.
Published: (2016)

PLGA-Chitosan nanoparticle-mediated gene delivery for oral cancer treatment: A brief review
by: Bakar, Latifah Munirah, et al.
Published: (2017)

Formulation of chitosan-based nanoparticles for delivery of proteins and peptides
by: Vellore Janarthanan, Mohanraj
Published: (2003)

GLP-1 promoter mediated insulin expression for the treatment of diabetes.
by: Ahmad, Zalinah, et al.
Published: (2010)

Design of pectin-chitosan nanoparticles as oral insulin carrier / Syed Mohamad Al-Azi Syed Othman
by: Syed Othman, Syed Mohamad Al-Azi
Published: (2015)

Nanoparticles-in-beads made of alginate and chitosan derivatives as oral insulin carrier / Mulham Alfatama
by: Alfatama, Mulham
Published: (2018)

The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable ß-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies.
by: Mooranian, A., et al.
Published: (2015)

PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)

Development and evaluation of polymeric nanoparticle formulations for triamcinolone acetonide delivery
by: Nastiti, Christofori Maria Ratna Rini
Published: (2007)